Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: A multicenter, open-label study

被引：29

作者：

Snydman, DR

Falagas, ME

Avery, R

Perlino, C

Ruthazer, R

Freeman, R

Rohrer, R

Fairchild, R

O'Rourke, E

Hibberd, P

Werner, BG

机构：

[1] New England Med Ctr, Boston, MA 02111 USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[4] Emory Univ, Atlanta, GA 30322 USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

[6] Childrens Hosp, Boston, MA 02115 USA

[7] Harvard Univ, Sch Med, Boston, MA USA

[8] Massachusetts State Lib Inst, Boston, MA USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 04期

关键词：

D O I：

10.1016/S0041-1345(01)02101-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2571 / 2575

页数：5

共 22 条

[1] Prophylaxis of cytomegalovirus infection in liver transplantation - A randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir [J].

Badley, AD ;

Seaberg, EC ;

Porayko, MK ;

Wiesner, RH ;

Keating, MR ;

Wilhelm, MP ;

Walker, RC ;

Patel, R ;

Marshall, WF ;

DeBernardi, M ;

Zetterman, R ;

Steers, JL ;

Paya, CV .

TRANSPLANTATION, 1997, 64 (01) :66-73

[2] RISK-FACTORS FOR INVASIVE FUNGAL-INFECTIONS COMPLICATING ORTHOTOPIC LIVER-TRANSPLANTATION [J].

COLLINS, LA ;

SAMORE, MH ;

ROBERTS, MS ;

LUZZATI, R ;

JENKINS, RL ;

LEWIS, WD ;

KARCHMER, AW .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :644-652

[3] CYTOMEGALO-VIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION SUCCESSFULLY TREATED WITH THE COMBINATION OF GANCICLOVIR AND HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN [J].

EMANUEL, D ;

CUNNINGHAM, I ;

JULESELYSEE, K ;

BROCHSTEIN, JA ;

KERNAN, NA ;

LAVER, J ;

STOVER, D ;

WHITE, DA ;

FELS, A ;

POLSKY, B ;

CASTROMALASPINA, H ;

PEPPARD, JR ;

BARTUS, P ;

HAMMERLING, U ;

OREILLY, RJ .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) :777-782

[4] Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients [J].

Falagas, ME ;

Syndman, DR ;

Griffith, J ;

Ruthazer, R ;

Werner, BG ;

Rohrer, R ;

Freeman, R ;

Fairchild, R ;

Fawaz, K ;

Hoffman, MA ;

Kaplan, M ;

Gill, M ;

Rubin, RH ;

Dienstag, JL ;

Doran, M ;

ORourke, E ;

Vacanti, J ;

Jenkins, R ;

Lewis, WD ;

Hammer, S ;

Martin, M ;

Grady, GF ;

Leszczynski, J ;

Dougherty, N ;

Katz, A ;

Fausett, G ;

Platt, R ;

Cheeseman, SH ;

Pasternack, M ;

Gorbach, SL .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :275-+

[5] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [J].

Gane, E ;

Saliba, F ;

Valdecasas, GJC ;

OGrady, J ;

Pescovitz, MD ;

Lyman, S ;

Robinson, CA .

LANCET, 1997, 350 (9093) :1729-1733

[6] The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients [J].

George, MJ ;

Snydman, DR ;

Werner, BG ;

Griffith, J ;

Falagas, ME ;

Dougherty, NN ;

Rubin, RH .

AMERICAN JOURNAL OF MEDICINE, 1997, 103 (02) :106-113

[7] SYMPTOMATIC CYTOMEGALO-VIRUS INFECTION AS A SIGNIFICANT RISK FACTOR FOR MAJOR INFECTIONS AFTER CARDIAC TRANSPLANTATION [J].

GORENSEK, MJ ;

STEWART, RW ;

KEYS, TF ;

MCHENRY, MC ;

BABIAK, T ;

GOORMASTIC, M .

JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04) :884-887

[8] PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS ANTIBODY-POSITIVE RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED CONTROLLED TRIAL [J].

HIBBERD, PL ;

TOLKOFFRUBIN, NE ;

CONTI, D ;

STUART, F ;

THISTLETHWAITE, JR ;

NEYLAN, JF ;

SNYDMAN, DR ;

FREEMAN, R ;

LORBER, MI ;

RUBIN, RH .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :18-26

[9] Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients [J].

Kusne, S ;

Grossi, P ;

Irish, W ;

St George, K ;

Rinaldo, C ;

Rakela, J ;

Fung, J .

TRANSPLANTATION, 1999, 68 (08) :1125-1131

[10] GANCICLOVIR PROPHYLAXIS DECREASES FREQUENCY AND SEVERITY OF CYTOMEGALOVIRUS DISEASE IN SEROPOSITIVE LIVER-TRANSPLANT RECIPIENTS TREATED WITH OKT3 MONOCLONAL-ANTIBODIES [J].

LUMBRERAS, C ;

OTERO, JR ;

HERRERO, JA ;

GOMEZ, R ;

LIZASOAIN, M ;

AGUADO, JM ;

COLINA, F ;

GARCIA, I ;

MORENO, E ;

NORIEGA, AR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2490-2492

← 1 2 3 →